$0.06 (15.5%)
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Xiaoqiu Zhang |
| Industry | Household & Personal Products |
| Sector | Consumer Defensive |
| Current Symbol | BYAH |
| CUSIP | G6925R110 |
| CIK | 0001986247 |
| Web | https://www.parkha.cn/ |
| Phone | 86 40 0012 7562 |
| Currency | USD |
| Employees | 41 |
| Country | CN |
Liquidity
| Debt-to-Equity Ratio | 0.05 |
| Payout Ratio | 0.00 |
| Current Ratio | 2.92 |
| Quick Ratio | 2.88 |
| Cash Ratio | 2.01 |
Sales & Book Value
| Annual Sales | $2.52M |
| Price / Sales | 0.10 |
| Cash Flow | -0.21 |
| Price / Cash Flow | -2.51 |
| Price / Book | 0.07 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-41.38 |
| Trailing P/E Ratio | -0.01 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-24.36M |
| Net Margin | -840.65% |
| Pretax Margin | -830.19% |
| Return on Equity | -652.67% |
| Return on Assets | -447.35% |
Financials Score
| AltmanZ Score | |
| Piotroski Score | |
| Working Capital | - |
| Total Assets | - |
| Ebit | - |
| Market Cap | - |
| Total Liabilities | - |
About Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ:BYAH) Stock
This enterprise functions as an investment holding company, with its core business centered on crafting and distributing skincare solutions. Operating under the "Park Ha" brand, these products are sold across the People's Republic of China. The company executes these activities through its affiliated subsidiaries, which manage both direct product sales and the provision of franchise services. ...
2026-07-06 14:15:00
Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co. , Ltd. (NASDAQ: BYAH) ("Park Ha Biological" or the "Company") announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed.
2026-07-06 14:15:00
Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed. This successful entry represents a critical milestone in the execution of the Company's global expansion strategy, reflecting the Amazon platform's authoritative recognition of Park Ha Biological's overall brand strength, core product competitiveness, and standardized operational excellence.
2026-07-01 08:00:00
Wuxi, China, July 01, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has formally filed a complete membership application with the Personal Care Products Council (PCPC).
2026-06-29 10:14:05
Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co. , Ltd. (NASDAQ: BYAH) ("Park Ha Biological" or the "Company") announced significant progress in its global expansion by initiating cooperation with Amazon ("Amazon") North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business.
2026-06-29 10:14:00
Wuxi, China, June 29, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced significant progress in its global expansion by initiating cooperation with Amazon (“Amazon”) North America and commencing full-scale preparations for entry into the North American personal care market, marking a key step toward the implementation of its overseas online business. Currently, four key tasks are advancing concurrently: store qualification registration, Amazon brand registry enrollment, establishment of a compliance framework for the North American market, and planning of localized product operation strategies. All preparatory efforts are being executed efficiently and systematically, with overall progress advancing ahead of schedule. This signifies that Park Ha Biological's online commercialization strategy in North America has entered a substantive implementation phase, laying a solid foundation for the launch of its flagship stores and sustained overseas operations.
2026-06-23 08:00:00
Wuxi, China, June 23, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that the Company has established a comprehensive strategic partnership with Cloud Factory Technology Holdings Limited (02512.HK), a company listed on The Stock Exchange of Hong Kong (“Cloud Factory”).
Park Ha Biological Technology Co., Ltd. Announces Closing of $2.0 Million Registered Direct Offering
2026-06-15 16:30:00
Wuxi, China, June 15, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), today announced the closing of its previously announced registered direct offering with several investors for the sale and purchase of an aggregate of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the “Class A Ordinary Shares”), and pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 200,000 Class A Ordinary Shares, at a combined purchase price of $1.50 per Class A Ordinary Share and Pre-Funded Warrant.
Park Ha Biological Technology Co., Ltd. Announces Pricing of $2.0 Million Registered Direct Offering
2026-06-12 14:54:31
Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co. , Ltd. , (NASDAQ: BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the "Offering") consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.
Frequently Asked Questions
What is the current Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) stock price?
Park Ha Biological Technology Co., Ltd. Ordinary Shares(NASDAQ:BYAH) stock price is $0.4666 in the last trading session. During the trading session, BYAH stock reached the peak price of $53 while $0.39 was the lowest point it dropped to. The percentage change in BYAH stock occurred in the recent session was 15.5% while the dollar amount for the price change in BYAH stock was $0.06.
BYAH's industry and sector of operation?
The NASDAQ listed BYAH is part of Household & Personal Products industry that operates in the broader Consumer Defensive sector.
Who are the executives of BYAH?
Xiaoqiu Zhang
| Chief Executive Officer & Chairman of the Board
Xiaoyan Zhu
| Chief Financial Officer
Xinyu Li
| Chief Technology Officer & Product Manager
|
|
How many employees does BYAH have?
Number of BYAH employees currently stands at 41. BYAH operates from 901 & 901-2, Wuxi, JS 214000, CN.
Link for BYAH official website?
Official Website of BYAH is: https://www.parkha.cn/
How do I contact BYAH?
BYAH could be contacted at phone #86 40 0012 7562 and can also be accessed through its website. BYAH operates from 901 & 901-2, Wuxi, JS 214000, CN.
How many shares of BYAH are traded daily?
The average number of BYAH shares traded daily for last 3 months was 4.59M.
What is the market cap of BYAH currently?
The market value of BYAH currently stands at $316.1K with its latest stock price at $0.4666